These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35618631)

  • 1. Neurovascular-Sparing MR-Guided Adaptive Radiotherapy in Prostate Cancer; Defining the Potential Population for Erectile Function-Sparing Treatment.
    Teunissen FR; van der Voort van Zyp JRN; Verkooijen HM; Wortel RC
    J Sex Med; 2022 Jul; 19(7):1196-1200. PubMed ID: 35618631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients.
    Teunissen FR; Wortel RC; Hes J; Willigenburg T; de Groot-van Breugel EN; de Boer JCJ; van Melick HHE; Verkooijen HM; van der Voort van Zyp JRN
    Phys Imaging Radiat Oncol; 2021 Oct; 20():5-10. PubMed ID: 34604553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.
    Teunissen FR; Wortel RC; Wessels FJ; Claes A; van de Pol SMG; Rasing MJA; Meijer RP; van Melick HHE; de Boer JCJ; Verkooijen HM; van der Voort van Zyp JRN
    Clin Transl Radiat Oncol; 2022 Jan; 32():29-34. PubMed ID: 34825071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
    Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
    Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.
    Ciabatti S; Ntreta M; Buwenge M; Gaudiano C; Sessagesimi E; Romani F; Angelini AL; Cammelli S; Macchia G; Deodato F; Zamagni A; Golfieri R; Morganti AG; Cilla S
    Med Dosim; 2019 Winter; 44(4):356-364. PubMed ID: 30955990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy (RRP): a potential diagnostic tool for optimal management of erectile dysfunction after RRP.
    Sciarra A; Panebianco V; Salciccia S; Alfarone A; Gentilucci A; Lisi D; Passariello R; Gentile V
    J Sex Med; 2009 May; 6(5):1430-7. PubMed ID: 19473289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of neurovascular bundle formation observed on preoperative magnetic resonance imaging regarding postoperative erectile function after nerve-sparing radical retropubic prostatectomy.
    Lee SE; Hong SK; Han JH; Han BK; Yu JH; Jeong SJ; Byun SS; Lee HJ
    Urology; 2007 Mar; 69(3):510-4. PubMed ID: 17382155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily online contouring and re-planning versus translation-only correction in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.
    Teunissen FR; van der Voort van Zyp JRN; de Groot-van Breugel EN; Verkooijen HM; Wortel RC; de Boer JCJ
    Phys Imaging Radiat Oncol; 2022 Oct; 24():43-46. PubMed ID: 36148156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.
    Sridhar AN; Cathcart PJ; Yap T; Hines J; Nathan S; Briggs TP; Kelly JD; Minhas S
    J Sex Med; 2016 Mar; 13(3):435-43. PubMed ID: 26944466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective comprehensive assessment of sexual function after retropubic non nerve sparing radical prostatectomy for localized prostate cancer.
    Trinchieri A; Nicola M; Masini F; Mangiarotti B
    Arch Ital Urol Androl; 2005 Dec; 77(4):219-23. PubMed ID: 16444937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review.
    Le Guevelou J; Sargos P; Ferretti L; Supiot S; Pasquier D; Créhange G; Blanchard P; Hennequin C; Chapet O; Schick U; Baty M; Masson I; Ploussard G; De Crevoisier R; Latorzeff I
    Eur Urol Oncol; 2024 Jun; 7(3):332-343. PubMed ID: 37640583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurovascular bundle-sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility study.
    Cassidy RJ; Yang X; Liu T; Thomas M; Nour SG; Jani AB
    Med Dosim; 2016 Winter; 41(4):339-343. PubMed ID: 27745996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT).
    Wolfe S; Diven MA; Marciscano AE; Zhou XK; Kishan AU; Steinberg ML; Miccio JA; Camilleri P; Nagar H
    BMC Cancer; 2023 Sep; 23(1):923. PubMed ID: 37777738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between doses to anatomical structures and erectile dysfunction after radiotherapy for prostate cancer: A systematic review].
    Ailloud A; Udrescu C; Horn S; Enachescu C; Créhange G; Sargos P; Supiot S; Zilli T; Lapierre A; Chapet O
    Cancer Radiother; 2023 Sep; 27(6-7):548-561. PubMed ID: 37596125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction?
    Rossi MS; Moschini M; Bianchi M; Gandaglia G; Fossati N; Dell'Oglio P; Schiavina R; Brunocilla E; Farina E; Picozzi M; Salonia A; Montorsi F; Briganti A
    J Sex Med; 2016 Apr; 13(4):669-78. PubMed ID: 27045263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with
    Chasseray M; Dissaux G; Bourbonne V; Boussion N; Goasduff G; Malloreau J; Malhaire JP; Fournier G; Tissot V; Pradier O; Valeri A; Schick U
    Acta Oncol; 2019 Jul; 58(7):1029-1035. PubMed ID: 30761939
    [No Abstract]   [Full Text] [Related]  

  • 17. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy.
    Mulhall JP; Klein EA; Slawin K; Henning AK; Scardino PT
    J Sex Med; 2018 Sep; 15(9):1293-1299. PubMed ID: 30224019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
    Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
    Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective characterization of nerve sparing predicts recovery of erectile function after radical prostatectomy: defining the utility of a nerve sparing grading system.
    Moskovic DJ; Alphs H; Nelson CJ; Rabbani F; Eastham J; Touijer K; Guillonneau B; Scardino PT; Mulhall JP
    J Sex Med; 2011 Jan; 8(1):255-60. PubMed ID: 20727065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review.
    van der Wielen GJ; Mulhall JP; Incrocci L
    Radiother Oncol; 2007 Aug; 84(2):107-13. PubMed ID: 17707936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.